Patrick Campbell is the assistant managing editor of Endocrinology Network, as well as its sister publications Practical Cardiology and Rheumatology Network. Prior to joining these brands, he led coverage of cardiology and diabetes with HCPLive. Before joining parent company MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a freelance multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Articles

Data from a pair of Washington, DC-based medical centers are providing an overview of the impact gender-affirming hormone therapy can have on blood pressure in transgender individuals. 

Hormone Therapy Can Alter Blood Pressure in Transgender Individuals

An analysis of claims data by investigators at University of Pennsylvania indicates DOACs were associated with a 36% lower risk of stroke or systemic embolism and was also associated with a reduction in risk of major bleeding.

DOACs May be More Effective than Warfarin for Valvular AFib

An analysis of more than 2k HFrEF patients from the CHAMP-HF registry indicates changes in KCCQ-OS may be a more accurate way of capturing changes in disease state than New York Heart Association class. 

Patient-Reported Outcomes Best NYHA Class for Capturing Progression of Heart Failure

An analysis comparing propensity-matched data from 4k transgender is providing an updated overview of the risk profile for patients undergoing gender-affirming therapy compared to their cisgender counterparts. 

Transgender Youth at Risk of Adverse Cardiometabolic Health, ENDO 2021 Study Finds

Results from a systematic review and meta-analysis of more than 50 studies assessing cardiovascular risk with levels of abdominal aortic calcification indicate increased AAC was linked to 80% increase in risk of cardiovascular events and cardiovascular death.

Abdominal Aortic Calcification Tied to 80% Increase in Risk of CV Events, Death

An analysis of data from Geisinger suggests living closer to fracking activity could increase a person's risk of hospitalization for heart failure. 

Proximity to Fracking Activity Linked to Increased Risk of Heart Failure Hospitalization

Results of the SCOPE II trial from TCT Connect offer insight into the head-to-head comparison of ACURATE neo valve versus the CoreValve Evolut R System. 

ACURATE neo Valve Fails to Demonstrate NonInferiority vs CoreValve Evolut in SCOPE II

A trial presented at TCT 2020 suggests crushed prasugrel provided no reperfusion benefit when compared against integral tablet in STEMI patients. 

Crushed Prasugrel Prior to PCI Provides No Reperfusion Benefit in STEMI Patients 

A meta-analysis published in JAMA Cardiology details reductions in cardiovascular and kidney outcomes associated with SGLT2 inhibitor use in diabetes patients.

Analysis of SGLT2 Inhibitor Outcomes Trials Details Cardiovascular, Renal Benefits

Gregory Weiss, MD, reflects on the idea of creating a cardiometabolic subspecialty. 

Research